Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
October 11, 2021 4:47 PM 5 min read

21Vianet Looks for New Chapter With Name Change

by Bamboo Works Benzinga Contributor
Follow

Key takeaways

  • 21Vianet’s shareholders have approved changing its name to VNET Group
  • The move marks the latest change for the company, following the arrival of new CFO in April and the recent departure of its COO

By Doug Young

With all the turbulence in U.S.-China relations, 2021 could well go down as the year of the name change for U.S.-listed Chinese companies.

Datacenter stalwart 21Vianet Group Inc. (NASDAQ:VNET) has become the latest Chinese company to jump on the name-changing bandwagon, with its announcement that shareholders approved the renaming of the company as VNET Group Inc. at a special meeting in Beijing last Friday. It first announced the plan with the release of its latest quarterly results on Aug. 24.

The company didn’t give too much explanation for the change, saying only on its latest quarterly earnings call it believed the move would promote its brand awareness.

Whether or not investors liked the change, 21Vianet’s shares rose 25% in the two days after the announcement, more likely due largely to its quarterly results.

The stock has given back most of those gains since the initial jump but is still up about 6% from before the name-change announcement. The reality is that name changes probably have a relatively little short-term impact on a company’s performance. But they could help over the longer term by better communicating to customers, business partners and investors what the company does.

That element is particularly important for Chinese companies that have listed overseas since many have used their Chinese names that mean little or nothing to most U.S.-based investors. More recently, having a non-Chinese-sounding name may also be taking on a political dimension, helping to distance those companies from growing China-U.S. tensions.

China has expressed its desire to slow or halt the stream of its tech companies listing in the U.S., hoping many will choose to list on one of its domestic markets instead. At the same time, the U.S. has temporarily halted new listings by Chinese companies until they can agree on language that will adequately educate U.S investors about risks associated with an unusual corporate structure used by most U.S.-listed Chinese firms.

Wearable device maker Huami kicked off the name-changing trend in February when it announced it would change its English name to Zepp Health Corp. (NYSE:ZEPP), a U.S.-based brand it had acquired earlier. That was followed by an August announcement from the Tinder-like Momo that it would change its name, which means “stranger” in Chinese, to the friendlier Hello Group Inc. (NASDAQ:MOMO). And late last month the more recently-listed smartphone recycling specialist AiHuiShou (NYSE:RERE) announced a plan to change its name to ATRenew Inc.

Among the name changes we’ve mentioned 21Vianet’s seems the least imaginative, with the company simply adopting its stock ticker symbol as its new name. Perhaps it thought the “21” element, probably a reference to the 21st century, had become outdated. Or maybe it simply wanted to use all capital letters to make its name stand out more, a common practice among many companies these days. Or maybe it was just looking for a new beginning.

Attention Needed

In fact, it’s probably not a bad thing that 21Vianet may be seeking a new beginning. It has emerged as a recent laggard among China’s three major independent data center operators, which also include the larger GDS Holdings (NASDAQ:GDS) and Chindata (NASDAQ:CD).

21Vianet has an important ally in global software giant Microsoft (MSFT.US), which offers its Azure-based cloud services in China using 21Vianet’s data centers due to Beijing’s prohibition on foreign ownership of telecoms infrastructure. But it hasn’t been able to capitalize on that arrangement, with the domestic cloud market dominated by internet giants Alibaba, Tencent and Baidu, as well as telecoms giant Huawei.

Still, a market of China’s size has plenty of room for everyone, including 21Vianet. The problem is that the company’s growth has been consistently slower than its rivals, making it a less attractive choice among investors.

The company posted 30.8% revenue growth in this year’s second quarter year-on-year, generating 1.5 billion yuan ($233 million), according to its latest results released in late August. That was far slower than Chindata’s 64% revenue growth, and also trailed the 38.9% growth for GDS, even though GDS is more than four times larger than 21Vianet in terms of market cap.

The trends also don’t look that good for 21Vianet. The company boosted its cabinets under management – a measure of capacity – by 43% year-on-year to 62,876 in the second quarter. But its revenue rose by the far-slower 30.8% that we mentioned above, indicating it was probably lowering prices to sell the new capacity.

At the same time, its compound utilization rate fell to 59.9% in the second quarter from 61.7% in the first quarter and 61.4% a year earlier. The company also gave guidance for 23% revenue growth in the third quarter, which would represent a slowdown from the second quarter.

21Vianet did manage to post a profit in the second quarter thanks to gains from the change in value of some of its convertible notes. But analysts see it falling sharply into the red next year, and Chindata is the only one of the three companies that’s currently operating profitably.

That might explain why Chindata’s price-to-sales (P/S) ratio is far higher than 21Vianet, with the former at 1.44 versus 0.45 for 21Vianet. GDS has an even higher P/S at 1.66.

At the end of the day, 21Vianet is a company in need of change and actively looking for it. The name change is just the latest example of that. This year it also changed two of its top executives, starting with the naming of a new CFO in April. More recently it announced the departure of its COO Cai Chunfeng at the end of last month, without name a replacement.

Now we’ll just have to wait and see if all of those changes will produce positive results.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsSmall CapGlobalcontributors
CD Logo
CDChaince Digital Holdings Inc
$4.98-%
Overview
GDS Logo
GDSGDS Holdings Ltd
$46.10-0.04%
MOMO Logo
MOMOHello Group Inc
$6.48-%
RERE Logo
REREATRenew Inc
$5.61-0.71%
VNET Logo
VNETVNET Group Inc
$13.890.65%
ZEPP Logo
ZEPPZepp Health Corp
$23.31-%
CD Logo
CDChaince Digital Holdings Inc
$4.98-%
Overview
GDS Logo
GDSGDS Holdings Ltd
$46.10-0.04%
MOMO Logo
MOMOHello Group Inc
$6.48-%
RERE Logo
REREATRenew Inc
$5.61-0.71%
VNET Logo
VNETVNET Group Inc
$13.890.65%
ZEPP Logo
ZEPPZepp Health Corp
$23.31-%
Comments
Loading...